Images List Premium Download Classic

Prophylactic

Prophylactic-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Novel aryl-cyanoguanidine compounds
Bayer Pharma Aktiengesellschaft
April 12, 2018 - N°20180099937

The present invention relates to protein-lysine n-methyltransferase smyd2 (set and mynd domain-containing protein 2) inhibitors, in particular smyd2-inhibitory substituted cyanoguanidine- pyrazolines of general formula (i), wherein r1, r2, r3, r4 and r5 have the meaning as described and defined herein, as well as to pharmaceutical compositions comprising compounds according to the invention and to their prophylactic and therapeutic use for ...
Vaccine compositions and methods of use thereof
University Of Miami
April 12, 2018 - N°20180099032

Nanoparticle-based vaccines, compositions, kits and methods are used for the effective delivery of one or more antigens in vivo for vaccination and antibody (e. G., monoclonal antibody) production, and for the effective delivery of peptides, proteins, sirna, rna or dna to papcs or mhc class ii positive cells (e. G. Tumor cells). Antigens may be, for example, dna that results ...
Covalent complex of von willebrand factor and factor viii, compositions, and uses relating thereto
Csl Limited
April 05, 2018 - N°20180092966

The present invention relates to a covalent complex of von willebrand factor (vwf) and factor viii, wherein the complex is modified such that it has an extended half-life in vivo. The invention further relates to a method of producing the complex, as well as the therapeutic or prophylactic use of the complex for treating or preventing bleeding events.
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Lurasidone novel dosage regimens and use thereof for the treatment, prevention, and/or management of ...
Sumitomo Dainippon Pharma Co., Ltd.
April 05, 2018 - N°20180092909

Dosage regimens for at least one compound chosen from lurasidone and pharmaceutically acceptable salts, solvates, clathrates, and stereoisomers thereof are disclosed as are kits and methods for treatment and/or prevention of at least one cns disorder such as, for example, mixed depression and bipolar disorder, and management of at least one cns disorder, such as improving quality of life ...
Foreskin condom
April 05, 2018 - N°20180092768

A prophylactic condom for simulating the sensation and natural lubricating properties of an uncircumcised penis includes an open shaft section which is elastic as to hold and encase a penis of varying size and shape of and a distal head section having a wide diameter bulbous portion intended to fold down around the shaft section during sexual intercourse. The bulbous ...
Anti-il-6/il-6r antibodies and methods of use thereof
Novimmune, S.a.
March 29, 2018 - N°20180086839

This invention provides fully human monoclonal antibodies that recognize the il-6/il-6r complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Resuscitation device for victims of cardiorespiratory arrests
March 29, 2018 - N°20180085542

The resuscitation device includes a curved tube which is inserted into the mouth and the throat of the patient, a straight segment remaining on the outside, where two one-way safety valves are arranged, for preventing the return of fluid, said device also including a prophylactic mouthpiece used by the resuscitating person in order to blow the air, and a protective ...
Pharmaceutical composition for treating and/or preventing cancer
Toray Industries, Inc.
March 29, 2018 - N°20180085453

An object of the present invention is to identify a cancer antigen protein specifically expressed on the surface of cancer cells and provide use of an antibody targeting the cancer antigen protein as a therapeutic and/or prophylactic agent for cancer. A pharmaceutical composition for treating and/or preventing cancer comprising an antibody or a fragment thereof having immunological reactivity ...
Therapeutic and/or prophylactic agent for lewy body disease
Kyowa Hakko Kirin Co., Ltd.
March 29, 2018 - N°20180085373

The present invention provides a therapeutic and/or prophylactic agent and the like, comprising istradefylline as an active ingredient, for lewy body disease (for example, parkinson's disease dementia, diffuse lewy body disease, dementia with lewy bodies, movement disorder associated with lewy body disease and the like).
Humanized anti-cd40 antibodies and uses thereof
Primatope Therapeutics Inc.
March 22, 2018 - N°20180078640

The present disclosure relates to anti-cd40 antibodies, such as humanized anti-cd40 antibodies, that may be used in various therapeutic, prophylactic and diagnostic methods. The antibodies generally block the ability of cd40 to bind cd154 and do so without activating the cell expressing cd40 (e. G., a b cell). The present antibodies or fragments thereof may be used to reduce complications ...
Virus-like particle compositions and vaccines against epstein-barr virus infection and disease
The University Of Massachusetts
March 22, 2018 - N°20180078634

The present invention relates to prophylactic and/or therapeutic vaccines that contain newcastle disease virus (ndv) virus-like particles (vlps) comprising one or more epstein-barr virus (ebv) antigens. In one embodiment, the invention provides a recombinant virus-like particle (vlp) comprising, in operable combination, a) newcastle disease virus (ndv) matrix (m) protein, and b) one or more epstein-barr virus (ebv) antigens. The ...
Nanoparticle compositions and methods for treating or preventing tissue infections and diseases
Attostat, Inc.
March 22, 2018 - N°20180078580

Stabilized multi-component antimicrobial compositions for treating tissue diseases, infections or conditions include a first and second set of differently sized and/or differently shaped metal nanoparticles, and a stabilizing agent. Compositions and treatment methods may be used for treating tissue diseases, infections or conditions caused by microbial infections, such as bacteria, viral, and/or fungal infections, or for preventing the ...
Compositions for prevention/prophylactic treatment of poison ivy dermatitis
March 22, 2018 - N°20180078520

The present invention, in one or more embodiments, comprises derivatives of 3-n-pentadecylcatechol (poison ivy urushiol saturated congener) and/or 3-n-heptadecyl catechol (poison oak urushiol saturated congener) as compositions for the prevention and/or prophylactic treatment of contact dermatitis caused by poison ivy and poison oak. The present invention is also directed towards processes for making such compounds. Disclosed are compounds ...
Prophylactic Patent Pack
Download 224+ patent application PDFs
Prophylactic Patent Applications
Download 224+ Prophylactic-related PDFs
For professional research & prior art discovery
inventor
  • 224+ full patent PDF documents of Prophylactic-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
System and process for treatment of myopia
Ojai Retinal Technology, Llc
March 22, 2018 - N°20180078412

A process for preventing or treating myopia includes applying a pulsed energy, such as a pulsed laser beam, to tissue of an eye having myopia or a risk of having myopia. The source of pulsed energy has energy parameters including wavelength or frequency, duty cycle and pulse train duration, which are selected so as to raise an eye tissue temperature ...
Compositions for the treatment of fibrosis and fibrosis-related conditions
Vectus Biosystems Limited
March 15, 2018 - N°20180072682

The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of fibrosis and fibrosis-related conditions.
Increasing the half-life of a full-length or a functional fragment of variant anti-human tnf-alpha antibody
Dnx Biotech, Llc
March 08, 2018 - N°20180066049

Tumor necrosis factor-α (tnfα) promotes an inflammatory response resulting in many clinical problems associated with autoimmune disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa, and refractory asthma. Dysregulation of tnf production is implicated in a variety of human diseases including alzheimer's disease, cancer, major depression, and inflammatory bowel disease. These disorders ...
A cyclic peptide and a medicament, external preparation and cosmetic comprising said cyclic peptide
Igisu Co., Ltd.
March 08, 2018 - N°20180066020

The present invention is aimed for providing a novel peptide with a high drug efficacy and strong effect, a medicament or external preparation comprising it, specifically a prophylactic or therapeutic for dermatitis, rhinitis or alopecia, or a hair growth stimulant, a hair growing agent, an antipruritic or a skin-care product. The present invention achieved said aim by providing a cyclic ...
T-type calcium channel inhibitor
Fuso Pharmaceutical Industries, Ltd.
March 08, 2018 - N°20180065947

The present invention provides a t-type calcium channel inhibitor which is a compound represented by formula (1), a pharmaceutically acceptable salt of this compound or a solvate of this compound. The present invention also provides: this t-type calcium channel inhibitor; a pharmaceutical product containing this t-type calcium channel inhibitor; and a therapeutic agent or prophylactic agent for diseases, the effective action ...
Compounds, compositions and methods useful for cholesterol mobilization
Cerenis Therapeutics Holding Sa
March 08, 2018 - N°20180064718

The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.
Bace1 inhibitors
Hoffmann-la Roche Inc.
March 01, 2018 - N°20180057485

The present invention provides a compound of formula i, having bace1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and/or prophylactic treatment of e. G. Alzheimer's disease.
Particle conjugated prosthetic patches and methods of making and using thereof
Yale University
March 01, 2018 - N°20180055972

Composite prosthetic patches with covalently bound particles for controlled drug release, and methods of making and using thereof, have been developed. The particles may encapsulate one or more therapeutic, prophylactic or diagnostic agent(s). Generally, the prosthetic patches are decellularized extracellular matrix such as bovine or porcine pericardium or synthetic polymeric materials. The size of the particles ranges from between 1 ...
Loading